Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

Inclusion Criteria

• •The patient must have given his/her informed and signed consent
• •The patient must be insured or beneficiary of a health insurance plan
• •The patient is available for 1 month of follow-up
• •The patient understands and reads French
• •The patient has symptoms of overactive bladder resistant to first-line treatments (physiotherapy, anticholinergics)
• •The patient suffers from an overactive bladder confirmed by a urodynamic panel
• •The patient suffers from an overactive bladder unassociated with bladder obstruction as confirmed by flowmetry
• •The patient has primary (idiopathic) overactive bladder primary with normal urinalysis, abdominal and pelvic ultrasound, urine cytology + / - cystoscopy
• •The patient has no bleeding disorders, or the disorder is properly controlled after treatment